| Drug |
|
|
CARBAMAZEPINE CAPSULE |
|
|
CARBAMAZEPINE
SUSPENSION |
|
|
CARBAMAZEPINE TABLET, CHEWABLE |
|
|
CARBAMAZEPINE TABLET, XR |
|
|
DIVALPROEX CAPSULE , SR |
|
|
DIVALPROEX TABLET, EC |
|
|
DIVALPROEX TABLET,
ER |
|
|
GABAPENTIN CAPSULE |
Neurontin Renal
Dosing
Gabapentin-Induced Neurologic Toxicities |
|
LAMOTRIGINE TABLET |
|
|
LEVETIRACETAM TABLET |
|
|
LEVETIRACETAM INJECTION |
-
Levetiracetam injection
is recommended for formulary inclusion restricted to the following patients:
-
Patients unable to take
oral levetiracetam
-
Oral bioavailability
is 100% and is unaffected by food or enteral nutritional products
-
Equivalent IV and
oral doses result in equivalent Cmax, Cmin, and total systemic exposure
-
levetiracetam
injection cost approximately 13 times more than the oral tablets
-
Status epilepticus
after benzodiazepines (lorazepam) and fosphenytoin have failed
-
No randomized
control trials have been completed for this indication. Only case reports are
available.
-
Levetiracetam oral
tablets cost $2.27 per 500 mg versus $29.15 per 500 mg injection ($58.30 for
1000 mg, and $175 for 3000 mg injection). Fosphenytoin injection cost $120.76
per 1000 mg
-
Pharmacist will
contact ordering physicians to convert to oral therapy when the patient is
able to take oral medications or has a functional feeding tube.
|
|
MAGNESIUM INJECTION |
|
|
OXCARBAZEPINE |
|
|
TIAGABINE TABLET |
|
|
TOPIRAMATE TABLET |
|
|
VALPROATE
SYRUP |
|
|
VALPROIC ACID CAPSULE |
|
|
VALPROIC ACID INJECTION |
|
|
ZONISAMIDE |
|
|